About VBI Vaccines, Inc.

VBI Vaccines, Inc. (NASDAQ: VBIV) is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped (“e”) virus-like particle (“VLP”) vaccines that closely mimic the target virus. Our lead eVLP asset is a prophylactic Cytomegalovirus – more... 

Claimed Profile